SIRTURO (Janssen Products, LP)
Welcome to the PulseAid listing for the SIRTURO drug offered from Janssen Products, LP. This Diarylquinoline Antimycobacterial [EPC],Diarylquinolines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Products, LP |
| NON-PROPRIETARY NAME: | Bedaquiline Fumarate |
| SUBSTANCE NAME: | BEDAQUILINE FUMARATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Diarylquinoline Antimycobacterial [EPC],Diarylquinolines [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-12-28 |
| END MARKETING DATE: | 0000-00-00 |
SIRTURO HUMAN PRESCRIPTION DRUG Details:
| Item Description | SIRTURO from Janssen Products, LP |
| LABELER NAME: | Janssen Products, LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2012-12-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59676-701_c56031fe-df6c-40cc-ba5e-36b53206ce0b |
| PRODUCT NDC: | 59676-701 |
| APPLICATION NUMBER: | NDA204384 |
Other BEDAQUILINE FUMARATE Pharmaceutical Manufacturers / Labelers:
